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Introduction
Sepsis is an important cause of mortality and morbidity
for preterm and hospitalized newborn babies. Today, no
single test satisfies the criteria as being the ideal marker
for the early diagnosis of neonatal sepsis. Analysis of the
entire metabolome is a promising method for determin-
ing metabolic variations correlated with sepsis [1-6].
Metabolomics profiling and sepsis
Works on metabolomics concerning sepsis conducted
on animals and humans of different ages (newborn and
adults) have recently been published and are presented
in Table 1. In septic patients compared to controls (in
plasma and urine) it is possible to observe an increase
of metabolites which are part of the oxidative metabo-
lism of fatty acids (such as hydroxybutyrate, acylcarni-
tines and acetoacetate). Briefly stated, alterations in the
glucose metabolism in critical conditions can be seen as
a redistribution of glucose consumption from the mito-
chondrial oxidative phosphorylation to other metabolic
pathways, such as the production of lactate and the pen-
tose phosphate pathway. In the study by Fanos et al. [7]
a combined approach based on both nuclear magnetic
resonance (1)H-NMR) and gas-chromatography-mass
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Table 1 Metabolomic studies that have analyzed the metabolic profiles of septic patients and of experimental animals
(From ref. 6, mod.)
Author Population study Sample Metabolomic
analysis
Metabolite alterations
Fanos et al. 2014 9 septic newborns vs 16
control newborns
Urine GC-MS
1H NMR
Lactate, glucose, maltose, ribitol, ribonic acid, pseudo-uridine,
2,3,4 trihydroxybutiric acid, 2-ketpgluconic acid, 3,4
hydroxybutanoic acid, 3,4,5 trihydroxypentanoic acid <(GC-MS)
Acetate, acetone, citrate, creatinine, glycine, lactate, lysine,
glucose (1H-NMR)
Mickiewicz et al. 2013 60 septic shock vs 40
SIRS vs 40 control
pediatric patients
Serum 1H-NMR 2-hydroxybutyrate, 2-hydroxyisovalerate, lactate, glucose,
2-oxoisocaproate, creatine, creatinine, histidine, and
phenylalanine
Schmerler et al. 2012 74 SIRS vs 69 septic vs 16
control human adults
Blood LC-MS/MS Acylcarnitines and glycerophosphatidylcholines
Mickiewitz et al. 2014 39 septic shock adult
patients vs 20 ICU control
patients
Serum 1H-NMR Isobutyrate, phenylalanine, 2 hydroxyisovalerate,
myoinositol, acetylcarnitine, creatine, lactate, valine, arginine,
methanol, glucose, glycine
Liu et al. 2010 40 septic vs control rats Plasma UPLC–Q-TOF-
MS
Hypoxanthine, indoxyl sulfate, glucuronic acid, gluconic
acid, proline, uracil, nitrotyrosine, uric acid and trihydroxy
cholanoic acid
Lin et al. 2009 40 septic vs 20 control
rats
Serum 1H NMR Lactate, alanine, acetate, acetoacetate, hydroxybutyrate and
formate
Izquierdo-Garcìa et al.
2011
14 septic vs 14 control
rats
Lung tissue,
BALF and
serum
1H NMR Alanine, creatine, phosphoethanolamine and myoinositol
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spectrometry (GC-MS) techniques was used applied to
neonatal infections. The study population included 25
neonates: 9 patients had a diagnosis of sepsis and 16
were healthy controls. This study showed a unique
metabolic profile of the patients affected by sepsis com-
pared to non-affected ones with a statistically significant
difference between the two groups (p = 0.05). Mickie-
wicz et al [8] examined serum samples collected from
60 patients with septic shock (by Gram- and/or Gram+),
40 patients with SIRS and 40 healthy children by
nuclear magnetic resonance spectroscopy spectra. Some
of the metabolite concentrations were able to separate
between patient groups. The main messages from
the published studies are as follows. a) Metabolomics is
able to early diagnose the infection (in some cases in
preclinical conditions). b) Metabolomics is able to pre-
dict the outcome in single individuals and the AUC
values are close to 1. c) Metabolomics appears to be a
promising and useful instrument also in the diagnosis of
sepsis. d) In the next future some easy tools, like urinary
dipsticks, with the discriminant metabolites will be avail-
able in clinical settings, bedside.
Conclusions
Present-day methods and procedures for the diagnosis
of systemic neonatal infections are hindered by low sen-
sitivity and long response times. Metabolomics is show-
ing promise of becoming a most effective method, even
in neonatology and paediatrics.
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